| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 06/16/2009 | CA2476934C Stabilized tnfr-fc composition comprising arginine |
| 06/16/2009 | CA2388314C Imidazole derivatives as phosphodiesterase vii inhibitors |
| 06/16/2009 | CA2381097C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 06/16/2009 | CA2361936C Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| 06/16/2009 | CA2343732C Substituted .gamma.-phenyl-.delta.-lactones and analogs thereof and uses related thereto |
| 06/16/2009 | CA2192786C Cyclopeptolide inhibitors of adhesion molecules |
| 06/11/2009 | WO2009073628A2 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/11/2009 | WO2009073300A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/11/2009 | WO2009073186A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | WO2009072688A1 Composition for inhibition of trasplant rejection containing the cordyceps mycellia extract as an active ingredient |
| 06/11/2009 | WO2009072687A1 Composition for inhibition of trasplant rejection containing the phellinus linteus mycellia extract as an active ingredient |
| 06/11/2009 | WO2009072674A1 Agent for reducing intestinal toxic bacterium and food or pharmaceutical preparation comprising the same |
| 06/11/2009 | WO2009072654A1 Radical therapeutic agent for keloid and hypertrophic scar |
| 06/11/2009 | WO2009072629A1 Skin external preparation |
| 06/11/2009 | WO2009072598A1 Therapeutic agent for pruritus |
| 06/11/2009 | WO2009072527A1 Composition for autotransplantation or allotransplantation using dental pulp stem cell, and use of the composition |
| 06/11/2009 | WO2009071625A1 Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 06/11/2009 | WO2009071213A1 Anti-glycation properties of asicatic acid and madecassic acid |
| 06/11/2009 | WO2009071161A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | WO2008140565A3 Use of tumor necrosis factor receptor 14 antagonists for treating psoriasis |
| 06/11/2009 | WO2002065984A3 Compounds having retinoid-like activity |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090149556 Non-Tumorigenic Ointment/Cream Base for Topical Application |
| 06/11/2009 | US20090149538 Aspirin-Triggered Lipid Mediators |
| 06/11/2009 | US20090149536 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| 06/11/2009 | US20090149531 Chemical composition derived from p-hydroxyphenyl propionic acid for the treatment of psoriasis |
| 06/11/2009 | US20090149510 Compositions and methods for modulating a kinase cascade |
| 06/11/2009 | US20090149502 a mixture of 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one and an adrenergic agonist selected from the group consisting of albuterol, terbutaline, fenoterol, formoterol and salmeterol, used for the treatment of allergies, skin and respiratory system disorders |
| 06/11/2009 | US20090149460 New Compounds |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149422 Hemostatic material |
| 06/11/2009 | US20090149420 Novel compositions and use thereof for the treatment, co-treatment or prevention of inflammatory disorders |
| 06/11/2009 | US20090149399 Heterocyclic kinase inhibitors |
| 06/11/2009 | US20090149382 Modulation of lipid rafts |
| 06/11/2009 | US20090148541 Compositions and methods for the treatment of seborrhea |
| 06/11/2009 | US20090148511 Composition and method for dermatological treatment |
| 06/11/2009 | US20090148395 Biomedical foam articles |
| 06/11/2009 | US20090148394 Treatment of chronic ulcerous skin lesions |
| 06/11/2009 | CA2708065A1 Therapeutic agent for pruritus |
| 06/11/2009 | CA2708062A1 Radical therapeutic agent for keloid and hypertrophic scar |
| 06/11/2009 | CA2707663A1 Oxysterols for activation of hedgehog signaling, osteoinduction, antiadipogenesis, and wnt signaling |
| 06/11/2009 | CA2707585A1 Use of 4-oxobutanoic acid derivatives in the treatment of pathologies associated with immunological disorders |
| 06/11/2009 | CA2706898A1 Mequitazine for treating or preventing pathologies involving histamine h4 receptors |
| 06/11/2009 | CA2704266A1 [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta |
| 06/10/2009 | EP2067777A1 Oxepin derivative |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2066324A2 Cycloalkanopyrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors |
| 06/10/2009 | EP1601673B1 Fused heterocycles and uses thereof |
| 06/10/2009 | EP0854870B1 Substituted imidazoles having anti-cancer and cytokine inhibitory activity |
| 06/10/2009 | DE202009001822U1 Prophylaxemittel gegen Krebskrankheiten und erhöhte Hautspannungen Prophylaxis for cancer diseases and increased skin tension |
| 06/10/2009 | DE102007049612A1 Bioaktive Zusammensetzung für kosmetische Anwendungen Bioactive composition for cosmetic applications |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497598C Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 06/10/2009 | CN100497392C Antagonistic anti-hTNFSF13b Human antibodies |
| 06/10/2009 | CN100497388C Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof |
| 06/10/2009 | CN100497323C New heterocyclic oxime compounds, preparing process and medical composition thereof |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496579C Antipruritic compositions and compositions for wound healing |
| 06/10/2009 | CN100496511C Preparation method of Bingling ointment for curing burn and scald |
| 06/10/2009 | CN100496480C Personal care compositions comprising a zinc containing material in an aqueous surfactant composition |
| 06/10/2009 | CN100496448C Oil-in-water emulsion composition |
| 06/09/2009 | US7544853 C1 inhibitor with short half-life transient treatment |
| 06/09/2009 | US7544799 Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 06/09/2009 | US7544709 Derivatives of andrimide and moiramide B having antibacterial properties |
| 06/09/2009 | US7544703 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/09/2009 | US7544689 (2S3R)-3-{9-Isopropyl-6-[(pyridin-2-ylmethyl)-amino]-9H-purin-2-ylamino}-pentan-2-ol; treating proliferative disorders, viral disorders, CNS disorders, diabetes, stroke, alopecia or neurodegenerative; cancer, leukemia, psoriasis; cyclin-dependent kinase (CDK) inhibitors |
| 06/09/2009 | US7544684 Hydrazono-malonitriles |
| 06/09/2009 | US7544655 Novel amino acid sequences are within the carboxy termini of fibrinogen; useful for cell culture and cell separation |
| 06/09/2009 | US7544653 Additive cytoprotective effects of two bioactive regions of pro-opiomelanocortin hormone |
| 06/09/2009 | US7544485 Baldness related gene and the polypeptide encoded thereby, and uses |
| 06/09/2009 | US7544480 drug screening an antagonist which inhibits hydroxylation of hypoxia inducible factor or an agonist which promotes hydroxylation of hypoxia inducible factor; hydroxylation of asparagine; antitumor agent; use for radiotherapy or chemotherapy |
| 06/09/2009 | US7544374 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 06/09/2009 | US7544367 Chemical method of making a suspension, emulsion or dispersion of pyrithione particles |
| 06/09/2009 | US7544357 Administering an interferon antagonist and a FMS-like tyrosine kinase 3 ("Flt3") ligand antagonist, such as an anti-IFN-alpha antibody; in vitro assay for determining risk for developing an autoimmune disease |
| 06/09/2009 | CA2410706C Composition and applicator for topical substance delivery |
| 06/09/2009 | CA2403721C Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 06/09/2009 | CA2382037C Grape seeds, cold-pressed grape seed oil, crushed grape seeds and grape seed meal |
| 06/09/2009 | CA2337772C Skin and tissue care and/or treatment agent |
| 06/09/2009 | CA2261706C The use of growth factor modulating compounds |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/09/2009 | CA2155017C Vpr function and activity |
| 06/04/2009 | WO2009070431A1 Antihistamine/corticosteroid preparations for the treatment of atopic dermatitis |
| 06/04/2009 | WO2009070378A1 Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition |
| 06/04/2009 | WO2009069736A1 Nitrogenated compound |
| 06/04/2009 | WO2009068876A1 Compositions for the treatment of skin disorders |
| 06/04/2009 | WO2009040314A3 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 06/04/2009 | WO2009036751A3 Cosmetic or dermatological composition for topical application |
| 06/04/2009 | WO2009027753A4 Composition and method inhibiting inflammation |
| 06/04/2009 | US20090143469 Salts of nateglinide |
| 06/04/2009 | US20090143462 Products of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same |
| 06/04/2009 | US20090143455 Pyrazoles Useful in the Treatment of Inflammation |
| 06/04/2009 | US20090143413 Thiazole Derivatives as CXCR3 Receptor Modulators |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143372 Chemical compounds |
| 06/04/2009 | US20090143345 Thioamide derivatives as progesterone receptor modulators |
| 06/04/2009 | US20090143342 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| 06/04/2009 | US20090143319 Transcription factor decoy |
| 06/04/2009 | US20090143299 Novel antimicrobial peptides and use thereof |
| 06/04/2009 | US20090143295 Peptide-based antiacne reagents |